Login Register Cart 0
Generic placeholder image

Current HIV Research

Editor-in-Chief

ISSN (Print): 1570-162X
ISSN (Online): 1873-4251

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Effect of Non-Surgical Periodontal Therapy on Clinical Parameters of Periodontitis, Oral Candida spp. Count and Lactoferrin and Histatin Expression in Saliva and Gingival Crevicular Fluid of HIV-Infected Patients

Author(s): Atila V. V. Nobre, Tabata L. S. Polvora, Diana E. Ramos Peña, Kelly V. Villafuerte, Gilberto A. Silva, Ana Laura P. Ranieri, Leandro D. de Macedo, Karen M. L. Morejon, Benedito A. L. da Fonseca, Camila Tirapelli, Maria C. P. Saraiva, Bruno Pozzetto, Alan G. Lourenço and Ana Carolina F. Motta*

Volume 21, Issue 1, 2023

Published on: 29 December, 2022

Page: [27 - 34] Pages: 8

DOI: 10.2174/1570162X21666221129090503

Price: $65

Abstract

Background: Periodontitis (PDT) has gained attention in the literature with the increase in life expectancy of people living with HIV on combined antiretroviral therapy (cART). Thus, the search for inflammatory biomarkers could be useful to understand the pathophysiology of chronic oral diseases in the cART era.

Objective: The aim of this study was to evaluate the impact of non-surgical periodontal therapy (NSPT) on clinical parameters of PDT, Candida spp. count and expression of lactoferrin (LF) and histatin (HST) in saliva and gingival crevicular fluid (GCF) of HIV-infected patients.

Methods: Bleeding index (BI), probing depth (PD), clinical attachment level (CAL), colonyforming units (CFUs) of Candida spp, and LF and HST levels were measured in saliva and GCF of both groups at three different times: baseline (before treatment), and 30 and 90 days after the NSPT. Clinical, mycological and immunoenzymatic analyses were also performed.

Results: Twenty-two HIV-infected patients and 25 non-HIV-infected patients with PDT participated in the study. NSPT was effective in improving periodontal clinical parameters, including ≤ 4 sites with PD ≤ 5mm and BI ≤ 10%. Significant change in oral Candida spp. count occurred neither between the two groups nor after NSPT. And the salivary and GCF levels of LF and HST were not influenced by the NSPT; by contrast, except for salivary LF, HST and LF were shown to exhibit significantly higher levels in HIV-infected than in non-HIV-infected patients.

Conclusion: NSPT was effective in improving periodontal disease parameters in HIV-infected patients, but did not affect LF and HST expression in saliva and GCF of HIV-infected patients.

Keywords: Candida species, HIV/AIDS, periodontitis, antimicrobial peptides, periodontal therapy, lactoferrin.

« Previous Next »
Graphical Abstract

[1]
UNAIDS.. Global HIV and AIDS statistics 2019 Fact sheet. Glob HIV AIDs statistics, World AIDS day 2020 Fact Sheet. Available from: https://www.unaids.org/en/resources/fact-sheet.
[2]
Brazil. Ministry of Health. Secretariat of Health Surveillance. HIV/AIDS Epidemiological Report, 2022 (in Portuguese). Available at: https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/ boletins/epidemiologicos/especiais/2022/boletim-epidemiologico-dehiv- aids-numero-especial-dez-2022/view. Accessed: December 14th, 2022.
[3]
Pólvora TLS, Nobre AVV, Tirapelli C, et al. Relationship between human immunodeficiency virus (HIV-1) infection and chronic periodontitis. Expert Rev Clin Immunol 2018; 14(4): 315-27.
[4]
EC-Clearinghouse on Oral Problems Related to HIV Infection and WHO Collaborating Centre on Oral Manifestations of the Immunodeficiency Virus. Classification and diagnostic criteria for oral lesions in HIV infection. J Oral Pathol Med 1993; 22(7): 289-91.
[PMID: 8229864]
[5]
Kinane DF, Lappin DF, Koulouri O, Buckley A. Humoral immune responses in periodontal disease may have mucosal and systemic immune features. Clin Exp Immunol 2001; 115(3): 534-41.
[http://dx.doi.org/10.1046/j.1365-2249.1999.00819.x] [PMID: 10193430]
[6]
Alpagot T, Konopka K, Bhattacharyya M, Gebremedhin S, Düzgüneş N. The association between gingival crevicular fluid TGF-β1 levels and periodontal status in HIV-1(+) patients. J Periodontol 2008; 79(1): 123-30.
[http://dx.doi.org/10.1902/jop.2008.070312] [PMID: 18166101]
[7]
Barr C, Lopez MR, Rua-Dobles A. Periodontal changes by HIV serostatus in a cohort of homosexual and bisexual men. J Clin Periodontol 1992; 19(10): 794-801.
[http://dx.doi.org/10.1111/j.1600-051X.1992.tb02173.x] [PMID: 1452807]
[8]
Berberi A, Noujeim Z. Epidemiology and relationships between CD4+ counts and oral lesions among 50 patients infected with human immunodeficiency virus. J Int Oral Health 2015; 7(1): 18-21.
[PMID: 25709361]
[9]
Cekici A, Kantarci A, Hasturk H, Van Dyke TE. Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontol 2000 2014; 64(1): 57-80.
[http://dx.doi.org/10.1111/prd.12002] [PMID: 24320956]
[10]
Ryder MI, Shiboski C, Yao TJ, Moscicki AB. Current trends and new developments in HIV research and periodontal diseases. Periodontol 2000 2020; 82(1): 65-77.
[http://dx.doi.org/10.1111/prd.12321] [PMID: 31850628]
[11]
Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 2003; 3(11): 685-702.
[http://dx.doi.org/10.1016/S1473-3099(03)00801-6] [PMID: 14592598]
[12]
Helmerhorst EJ, Oppenheim FG. Saliva: a dynamic proteome. J Dent Res 2007; 86(8): 680-93.
[http://dx.doi.org/10.1177/154405910708600802] [PMID: 17652194]
[13]
Grassl N, Kulak NA, Pichler G, et al. Ultra-deep and quantitative saliva proteome reveals dynamics of the oral microbiome. Genome Med 2016; 8(1): 44.
[http://dx.doi.org/10.1186/s13073-016-0293-0] [PMID: 27102203]
[14]
Castagnola M, Scarano E, Passali GC, et al. Salivary biomarkers and proteomics: future diagnostic and clinical utilities. Acta Otorhinolaryngol Ital 2017; 37(2): 94-101.
[http://dx.doi.org/10.14639/0392-100X-1598] [PMID: 28516971]
[15]
Rosa L, Lepanto MS, Cutone A, et al. Lactoferrin and oral pathologies: a therapeutic treatment. Biochem Cell Biol 2021; 99(1): 81-90.
[http://dx.doi.org/10.1139/bcb-2020-0052] [PMID: 32213143]
[16]
Groot F, Geijtenbeek TBH, Sanders RW, et al. Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN--gp120 interaction. J Virol 2005; 79(5): 3009-15.
[http://dx.doi.org/10.1128/JVI.79.5.3009-3015.2005] [PMID: 15709021]
[17]
Johnson EE, Wessling-Resnick M. Iron metabolism and the innate immune response to infection. Microbes Infect 2012; 14(3): 207-16.
[http://dx.doi.org/10.1016/j.micinf.2011.10.001] [PMID: 22033148]
[18]
Paquette DW, Waters GS, Stefanidou VL, et al. Inhibition of experimental gingivitis in beagle dogs with topical salivary histatins. J Clin Periodontol 1997; 24(4): 216-22.
[http://dx.doi.org/10.1111/j.1600-051X.1997.tb01834.x] [PMID: 9144043]
[19]
Nikawa H, Jin C, Makihira S, Hamada T, Samaranayake LP. Susceptibility of Candida albicans isolates from the oral cavities of HIV-positive patients to histatin-5. J Prosthet Dent 2002; 88(3): 263-7.
[http://dx.doi.org/10.1067/mpr.2002.127907] [PMID: 12426495]
[20]
Helmerhorst EJ, Hodgson R, van’t Hof W, Veerman ECI, Allison C, Nieuw Amerongen A. The effects of histatin-derived basic antimicrobial peptides on oral biofilms. J Dent Res 1999; 78(6): 1245-50.
[http://dx.doi.org/10.1177/00220345990780060801] [PMID: 10371248]
[21]
Lourenço A, Nakao C, Machado A, et al. Lactoferrin, a marker for periodontal disease. Curr HIV Res 2013; 11(3): 220-5.
[http://dx.doi.org/10.2174/1570162X11311030006] [PMID: 23432422]
[22]
Nobre ÁVV, Pólvora TLS, Silva LRM, et al. Effects of non-surgical periodontal therapy on clinical and immunological profile and oral colonization of Candida spp in HIV-infected patients with chronic periodontitis. J Periodontol 2019; 90(2): 167-76.
[http://dx.doi.org/10.1002/JPER.18-0197] [PMID: 30118537]
[23]
Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999; 4(1): 1-6.
[http://dx.doi.org/10.1902/annals.1999.4.1.1] [PMID: 10863370]
[24]
Caton JG, Armitage G, Berglundh T, et al. A new classification scheme for periodontal and peri-implant diseases and conditions - Introduction and key changes from the 1999 classification. J Clin Periodontol 2018; 45 (Suppl. 20): S1-8.
[http://dx.doi.org/10.1111/jcpe.12935] [PMID: 29926489]
[25]
Feres M, Retamal-Valdes B, Faveri M, et al. Proposal of a Clinical Endpoint for Periodontal Trials: The Treat-to-Target Approach. J Int Acad Periodontol 2020; 22(2): 41-53.
[PMID: 32224549]
[26]
Singh PK, Parsek MR, Greenberg EP, Welsh MJ. A component of innate immunity prevents bacterial biofilm development. Nature 2002; 417(6888): 552-5.
[http://dx.doi.org/10.1038/417552a] [PMID: 12037568]
[27]
Yadav N, Lamba AK, Thakur A, Faraz F, Tandon S, Pahwa P. Effect of periodontal therapy on lactoferrin levels in gingival crevicular fluid. Aust Dent J 2014; 59(3): 314-20.
[http://dx.doi.org/10.1111/adj.12203] [PMID: 24913177]
[28]
Wakabayashi H, Kondo I, Kobayashi T, et al. Periodontitis, periodontopathic bacteria and lactoferrin. Biometals 2010; 23(3): 419-24.
[http://dx.doi.org/10.1007/s10534-010-9304-6] [PMID: 20155438]
[29]
Jang WS, Bajwa JS, Sun JN, Edgerton M. Salivary histatin 5 internalization by translocation, but not endocytosis, is required for fungicidal activity in Candida albicans. Mol Microbiol 2010; 77(2): 354-70.
[http://dx.doi.org/10.1111/j.1365-2958.2010.07210.x] [PMID: 20487276]
[30]
Sugimoto J, Kanehira T, Mizugai H, Chiba I, Morita M. Relationship between salivary histatin 5 levels and Candida CFU counts in healthy elderly. Gerodontology 2006; 23(3): 164-9.
[http://dx.doi.org/10.1111/j.1741-2358.2006.00120.x] [PMID: 16919097]
[31]
Jentsch H, Sievert Y, Göcke R. Lactoferrin and other markers from gingival crevicular fluid and saliva before and after periodontal treatment. J Clin Periodontol 2004; 31(7): 511-4.
[http://dx.doi.org/10.1111/j.1600-051X.2004.00512.x] [PMID: 15191585]
[32]
Ray S, Narayanan A, Giske CG, Neogi U, Sönnerborg A, Nowak P. Altered gut microbiome under antiretroviral therapy: Impact of efavirenz and zidovudine. ACS Infect Dis 2021; 7(5): 1104-15.
[http://dx.doi.org/10.1021/acsinfecdis.0c00536] [PMID: 33346662]

Rights & Permissions Print Cite
Article Metrics
49
2
World Immunization Week
© 2024 Bentham Science Publishers | Privacy Policy